Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
MEDIFAST INC
Bear Case (25th pct.)
21.7% vs price
Base Case (Median)
22.8% vs price
Bull Case (75th pct.)
23.9% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| EV/EBITDA | $14.79 | 25.0% | Medium (20%) |
| EV/FCF | $14.27 | 20.6% | Medium (20%) |
Based on 2 out of 7 methods, MED appears undervalued at the current price of $11.83. The base case fair value of $14.53 implies 22.8% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.